Clinical Trials Browser

Phase 1 × Thyroid Neoplasms × dabrafenib × Clear all

NCT01947023 2025-11-05

Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Phase 1 Active not recruiting

Thyroid Neoplasms